Hannelius, U., Beam, C. A., & Ludvigsson, J. (2020). Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes. Diabetologia.
استشهاد بنمط شيكاغوHannelius, Ulf, Craig A. Beam, و Johnny Ludvigsson. "Efficacy of GAD-alum Immunotherapy Associated With HLA-DR3-DQ2 in Recently Diagnosed Type 1 Diabetes." Diabetologia 2020.
MLA استشهادHannelius, Ulf, Craig A. Beam, و Johnny Ludvigsson. "Efficacy of GAD-alum Immunotherapy Associated With HLA-DR3-DQ2 in Recently Diagnosed Type 1 Diabetes." Diabetologia 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.